Startup Funding News

Explore funding rounds, the companies behind them and the investors taking part.

Rounds
2,145
Jul 29 – Oct 26, 2026
Disclosed funding
$145.3B
1469 disclosed amounts
Median round
$10M
Of disclosed amounts
2,145 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
FuroClimate tech · GermanyCompany profile

Furo provides AI software that plans, controls and optimizes commercial and industrial battery-storage systems, including their participation in energy markets.

Furo provides AI software that plans, controls and optimizes commercial and industrial battery-storage systems, including their participation in energy markets.

$4MFunding roundUndisclosedClimate techGermanyInvestors
Connecta TherapeuticsBiotech · SpainCompany profile

Connecta Therapeutics develops small-molecule treatments for neurological disorders, including CTH120, a clinical-stage candidate for Fragile X syndrome.

Connecta Therapeutics develops small-molecule treatments for neurological disorders, including CTH120, a clinical-stage candidate for Fragile X syndrome.

€3.1MClinical development financingUndisclosedBiotechSpainInvestors
RunPilotClimate tech · United KingdomCompany profile

RunPilot helps infrastructure teams compare route and network options for major energy and linear infrastructure projects before committing to costly designs.

RunPilot helps infrastructure teams compare route and network options for major energy and linear infrastructure projects before committing to costly designs.

£140KEarly-stage fundingUndisclosedClimate techUnited KingdomInvestors
vyznProptech · SwitzerlandCompany profile

AI-assisted building-planning software that evaluates cost, carbon, energy use and occupant comfort from digital building models, giving architects and engineers comparable options early in design.

AI-assisted building-planning software that evaluates cost, carbon, energy use and occupant comfort from digital building models, giving architects and engineers comparable options early in design.

UndisclosedUndisclosed investmentUndisclosedProptechSwitzerlandInvestors
LuminaryFintech · United StatesCompany profile

Luminary helps wealth and legal professionals analyze estate plans and guide clients through wealth transfer decisions.

Luminary helps wealth and legal professionals analyze estate plans and guide clients through wealth transfer decisions.

$22MSeries AFintechUnited StatesInvestors
Sparkle Grooming Co.Consumer · United StatesCompany profile

A dog-grooming franchise pairs recurring memberships with standardized wellness-focused salon services.

A dog-grooming franchise pairs recurring memberships with standardized wellness-focused salon services.

$6MFundingUndisclosedConsumerUnited StatesInvestors
KittsEcommerce · GermanyCompany profile

Kitts is a marketplace where football-shirt fans can buy and sell jerseys and build a public collection of the kits they value.

Kitts is a marketplace where football-shirt fans can buy and sell jerseys and build a public collection of the kits they value.

UndisclosedStrategic investmentUndisclosedEcommerceGermanyInvestors
BiorsafEnterprise software · ItalyCompany profile

Biorsaf provides digital compliance software for food safety and related workplace and water-safety procedures across food businesses and consultants.

Biorsaf provides digital compliance software for food safety and related workplace and water-safety procedures across food businesses and consultants.

€5.2MSeries AEnterprise softwareItalyInvestors
Positron AIHardware · United StatesCompany profile

Positron AI develops memory-focused hardware and software for large-language-model inference.

Positron AI develops memory-focused hardware and software for large-language-model inference.

≤$875MSeries C and Series C-1 financing packageSeries C+HardwareUnited StatesInvestors
One BiosciencesBiotech · FranceCompany profile

Single-cell tumour profiling for oncology teams and pharma and biotech partners, turning routine biopsy samples into clinical insights for treatment selection and drug development.

Single-cell tumour profiling for oncology teams and pharma and biotech partners, turning routine biopsy samples into clinical insights for treatment selection and drug development.

€3.3Mi-Démo 5 grant (France 2030)UndisclosedBiotechFranceInvestors